Immucell (ICCC) Return on Equity [ROE] (2009 - 2026)
Immucell (ICCC) recorded Return on Equity [ROE] of 5.86% in Q3 2026, down 1.93 percentage points from 7.79% a year earlier but up 3.26 percentage points from the prior quarter.
Immucell (ICCC) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Immucell reported Return on Equity [ROE] of -3.81%, up 4.40 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -0.24 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -8.21% in FY2024 (+12.64 pp), -20.86% in FY2023 (-12.93 pp), -7.92% in FY2022 (-7.66 pp) and -0.26% in FY2021 (+3.31 pp).
- Quarterly Return on Equity [ROE] has ranged from -23.84% in Q3 2023 to 7.79% in Q3 2025 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has declined for three consecutive quarters, with an average year-over-year change of +9.17 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 23.07 percentage points in Q3 2025, against a drop of 24.75 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 2.60% (Q2 2026), -1.94% (Q1 2026) and -3.66% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 4.66% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 5.86% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.86% |
| Jun 30, 2026 | 2.60% |
| Mar 31, 2026 | -1.94% |
| Dec 31, 2025 | -3.66% |
| Sep 30, 2025 | 7.79% |
| Jun 30, 2025 | 5.99% |
| Mar 31, 2025 | -0.96% |
| Dec 31, 2024 | -8.00% |
| Sep 30, 2024 | -15.28% |
| Jun 30, 2024 | -16.84% |
| Mar 31, 2024 | -15.71% |
| Dec 31, 2023 | -22.64% |
| Sep 30, 2023 | -23.84% |
| Jun 30, 2023 | -21.88% |
| Mar 31, 2023 | -20.52% |
| Dec 31, 2022 | -8.55% |
| Sep 30, 2022 | -2.86% |
| Jun 30, 2022 | -0.36% |
| Mar 31, 2022 | 4.23% |
| Dec 31, 2021 | -0.24% |
Immucell Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();